TGA Approval

SALPLUSF DPI 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler (418491)

ARTG ID

418491

ARTG Name

SALPLUSF DPI 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler

Sponsor

Cipla Australia Pty Ltd

ARTG Date

January 3, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

CIPLA AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/f2c30670c786df6d7ec9c99f1736950a.pdf

https://medical-cdn.nocode.com/drug_tga/6f1afc93c12ee248635d98294f03a8f8.pdf

Ingredient Name

fluticasone propionate

Ingredient Name

salmeterol xinafoate

Empowering clinical research with data-driven insights and AI-powered tools.